Drug Database
Back to search

United States· US:43547-393_23c860d3-1b9a-4113-bab4-b803492bf7d7

OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE

A medicinal product containing olmesartan medoxomil; hydrochlorothiazide, registered in United States by Solco Healthcare US, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOLMESARTAN MEDOXOMIL and HYDROCHLOROT…ATC—REGISTER NO.US:43547-393_23c860d3…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about olmesartan medoxomil; hydrochlorothiazideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
Manufacturer
Solco Healthcare US, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    43547-393-03
  • ndc11
    43547-393-09
  • ndc11
    43547-393-11
  • ndc11
    4354739303
    30 TABLET in 1 BOTTLE (43547-393-03)
  • ndc11
    4354739309
    90 TABLET in 1 BOTTLE (43547-393-09)
  • ndc11
    4354739311
    1000 TABLET in 1 BOTTLE (43547-393-11)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Olmesartan medoxomil; hydrochlorothiazide in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil; hydrochlorothiazide products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Mencord Plus, Olmeblo Hct
  • Belgium · Belsar Plus, Co-Olmesartan
  • Bulgaria · Olmesartan/Hctz Mylan, Ко-Олиместра
  • Cyprus · Olartan-Plus, Olmesartan/Hydrochlorothiazide Tad
  • Czechia · Sarten Plus H, Zeota Hct
  • Germany · Olmecor Hct, Olmes Plus
  • Denmark · Olmesartan Medoxomil/Hydrochlorothiazide Krka
  • Estonia · Co-Olimestra, Mesar Plus
  • Spain · Atolme Plus, Ixia Plus
  • Finland · Olmesartan Medoxomil/Hydrochlorothiazide Krka
  • France · Alteisduo, Coolmetec
  • United Kingdom (Northern Ireland) · Olmesartan Medoxomil/Hydrochlorothiazide Accord Healthcare, Olmesartan Medoxomil/Hydrochlorothiazide Msn Laboratories Europe
  • Greece · Co-Ipertas, Olartan-Plus
  • Croatia · Co-Olimestra, Olmesartan/Hidroklorotiazid Genericon
  • Hungary · Laresin Plus
  • Ireland · Olmesartan/Hydrochlorothiazide Clonmel, Olmesartan/Hydrochlorothiazide Krka
  • Italy · Idalazide, Olmegan
  • Lithuania · Co-Olimestra, Mesar Plus
  • Luxembourg · Belsar Plus, Olmesartan Plus Hct
  • Latvia · Co-Olimestra, Mesar Plus
  • Malta · Olmesartan Medoxomil/Hydrochlorothiazide Msn, Olmesartan/ Hydrochlorothiazide Msn
  • Netherlands · Hydrochlorothiazide/ Olmesartan Medoxomil Aurobindo, Hydrochlorothiazide/Olmesartan Medoxomil Aurobindo
  • Norway · Olmesartan Medoxomil/Hydrochlorothiazide Krka
  • Poland · Co-Olimestra, Osaver Hct
  • Portugal · Olmesartan + Hidroclorotiazida Sandoz, Olmesartan Medoxomilo + Hidroclorotiazida Alter
  • Slovenia · Co-Tensiol, Olmicombi
  • Slovakia · Tenzar Plus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f19eaf8c-510e-46d0-bcaa-fdf1f3e5364f
GET /v1/drugs/f19eaf8c-510e-46d0-bcaa-fdf1f3e5364f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "40; 25",
  "substance": "OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE",
  "productndc": "43547-393",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA207804",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about olmesartan medoxomil; hydrochlorothiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console